News from clarity pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 09, 2020, 09:13 ET Clarity Pharmaceuticals Announces the US FDA Grants Rare Paediatric Disease Designation to 64Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the...


Jul 23, 2020, 09:13 ET Clarity Pharmaceuticals opens SARTATE neuroblastoma clinical trial

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has opened its...


Jul 21, 2020, 09:13 ET Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the...


Jun 03, 2020, 09:08 ET Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE™ for the Treatment of Neuroblastoma

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and...


Apr 21, 2020, 09:13 ET Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and...


Mar 31, 2020, 09:14 ET Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies...


Mar 20, 2020, 00:17 ET Prof. Oliver Sartor Joins Clarity's Advisory Board

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Prof. Oliver Sartor...


Apr 09, 2019, 21:30 ET Dr Gillies O'Bryan-Tear Joins Clarity Pharmaceuticals' Board

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies...


Mar 25, 2019, 20:30 ET Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is delighted to announce that Dr Thomas Ramdahl...